Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

NCT01380600 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Colorectal

Interventions

DRUG: Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)

Sponsor

Jennerex Biotherapeutics

Collaborators

[object Object]